PHARMAGEN, INC. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f570ef30-4bd6-4c34-8000-6f083a5462ee/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2013 | $4.8M | 2013-01-01 – 2013-12-31 | evidence 0001477932-14-001427 |
| FY 2012 | $3.9M | 2012-01-01 – 2012-12-31 | evidence 0001477932-14-001427 |
| FY 2011 | $262 | 2009-06-25 – 2011-12-31 | evidence 0001078782-12-000386 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).